Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.96 |
| ▸ | GAA | P10253 | 5/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.64 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | NSD2 | O96028 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | MPI | P34949 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etocarlide SCHEMBL103618 | 0.98 | MAPT (1.00) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL9263 | 0.98 | MAPT (1.00) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL4340235 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL9250 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL3794642 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL1506842 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL20658914 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL21694441 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL20994029 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E | |
| Etocarlide SCHEMBL3458484 | 0.96 | MAPT (0.96) | MAPTGAAL3MBTL1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250381550-A1 | CARBON DISULFIDE TREATED MATERIALS AND METHODS OF PURIFYING FLUIDS USING THE SAME | ZENITH PURIFICATION LLC (US) | 2025-12-18 | — | — | US | claimed |
| US-20240376024-A1 | METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI | FUDAN UNIVERSITY (CN) | 2024-11-14 | — | — | US | claimed |
| EP-4321499-A1 | METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI | Fudan University (CN) | 2024-02-14 | — | — | EP | claimed |
| WO-2024010846-A2 | CARBON DISULFIDE TREATED MATERIALS AND METHODS OF PURIFYING FLUIDS USING THE SAME | ZENITH PURIFICATION, LLC (US) | 2024-01-11 | — | — | WO | claimed |
| WO-2022214045-A1 | METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI | 复旦大学 | 2022-10-13 | — | — | WO | claimed |
| EP-1081144-A2 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | claimed |
| US-20250381550-A1 | CARBON DISULFIDE TREATED MATERIALS AND METHODS OF PURIFYING FLUIDS USING THE SAME | ZENITH PURIFICATION LLC (US) | 2025-12-18 | — | — | US | disclosed |
| WO-2025243002-A1 | FLUORINATION PROCESS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-11-27 | — | — | WO | disclosed |
| US-20250066547-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL AND TRANSESTERIFICATION CATALYST | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-02-27 | — | — | US | disclosed |
| CN-119161552-A | Composition, coating composition, aqueous polyurethane dispersion, polyurethane resin and polyurea resin | 旭化成株式会社 | 2024-12-20 | — | — | CN | disclosed |
| EP-4467591-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL, AND TRANSESTERIFICATION CATALYST | Asahi Kasei Kabushiki Kaisha (JP) | 2024-11-27 | — | — | EP | disclosed |
| US-20240376024-A1 | METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI | FUDAN UNIVERSITY (CN) | 2024-11-14 | — | — | US | disclosed |
| CN-118660923-A | Method for producing polycarbonate diol, and transesterification catalyst | 旭化成株式会社 | 2024-09-17 | — | — | CN | disclosed |
| EP-1081143-A1 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | disclosed |
| EP-1081144-A2 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | disclosed |
| EP-1081146-A1 | Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | disclosed |
| WO-2000076950-A1 | METHOD FOR MANUFACTURING DIALKYL CARBONATE | GENERAL ELECTRIC COMPANY (US) | 2000-12-21 | — | — | WO | disclosed |
| EP-0321174-B1 | Process for preparing aminopropyl silanes | TONEN CORP (JP) | 1994-03-23 | — | — | EP | disclosed |
| US-4921988-A | RHODIUM CATALYST, BASE, ALLYLAMINE | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1990-05-01 | — | — | US | disclosed |
| EP-0321174-A2 | Process for preparing aminopropyl silanes | Tonen Corporation (JP) | 1989-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250066547-A1 | METHOD FOR PRODUCING POLYCARBONATE DIOL, POLYCARBONATE DIOL AND TRANSESTERIFICATION CATALYST | CYP24A1, CCNE2, DHCR24 | MAPT 4249/4885GAA 2111/4885L3MBTL1 3232/4885 |
| US-20240376024-A1 | METHOD FOR PREPARING DEUTERATED CHEMICAL BY MEANS OF DEUTERATION REACTION OF CARBON-HYDROGEN BOND WITH DEUTERIUM GAS UNDER CATALYSIS OF ALKALI | HDHD5, DKC1, DEK | MAPT 3580/4885GAA 418/4885L3MBTL1 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.